Wilson Sonsini Advises Optum Ventures and Oxford Science Enterprises on Series B Investment in BehaVR - Wilson Sonsini Goodrich & Rosati

On December 13, 2022, virtual world intelligence and behavioral wellness companies BehaVR and OxfordVR announced their merger, supported by an archetypal $13 cardinal successful Series B backing led by Optum Ventures and Oxford Science Enterprises, with information from Confluent Health, Accenture Ventures, Chrysalis Ventures, and Thornton Capital. Wilson Sonsini Goodrich & Rosati advised pb investors Optum Ventures and Oxford Science Enterprises connected the transaction, successful collaboration with Taylor Wessing.

The operation of the 2 integer therapeutic companies creates the largest VR transportation level for evidence-based integer behavioral therapies and accelerates the combined company’s maturation strategy. Operating nether the BehaVR brand, the broad VR attraction level volition assistance providers, payers, and employers present and summation entree to enhanced behavioral care.

The Wilson Sonsini squad that advised Optum Ventures and Oxford Science Enterprises connected the transaction included: